Myocardial Infarction and Evolocumab
JAMA Cardiol
.
2021 Oct 1;6(10):1221-1222.
doi: 10.1001/jamacardio.2021.1997.
Author
Mohammad Alkhalil
1
2
Affiliations
1
Department of Cardiology, Toronto General Hospital, Toronto, Ontario, Canada.
2
Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
PMID:
34160556
DOI:
10.1001/jamacardio.2021.1997
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Humans
Myocardial Infarction* / drug therapy
Substances
Antibodies, Monoclonal, Humanized
evolocumab